Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience

BACKGROUND: Despite all the scientific progress that has been made on understanding the disease, prognosis for patients with relapsed and refractory Hodgkin's lymphoma remains poor and the treatment is palliative in the majority of the cases. Thus, the aim of this study was to present the resul...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Rev Bras Hematol Hemoter
Main Authors: Rocha, Talita Máira Bueno da Silveira da, Fortier, Sergio Costa, Fischer, Thais Rodrigues da Cunha, Perini, Guilherme Fleury, Gaiolla, Rafael Dezen, Fogliatto, Laura, Delamain, Marcia Torresan, Costa, Andressa Fragoso da, Castro, Nelson Siqueira de, Barretos, Wolney Gois, Souza, Cármino Antonio de, Buccheri, Valéria, Chiattone, Carlos Sérgio
Format: Artigo
Sprog:Inglês
Udgivet: Sociedade Brasileira de Hematologia e Hemoterapia 2017
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5567422/
https://ncbi.nlm.nih.gov/pubmed/28830600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bjhh.2017.03.008
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker